Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Primary Chemotherapy in Patients With HER2-positive Early Breast Cancer (LAPADO)

This study has been completed.
Information provided by (Responsible Party):
Prof Dirk Elling, Sana-Klinikum Lichtenberg Identifier:
First received: July 28, 2010
Last updated: November 1, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)